Holen Sie sich die Stockscreener-App
3.91
5.39%
0.20
Vorhandelsmarkt:
3.87
-0.04
-1.02%
Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten
Ironwood Pharmaceuticals Inc (IRWD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Ironwood Pharmaceuticals Inc (IRWD) Institutional Confidence - TradingKey
Total operating expenses of Ironwood Pharmaceuticals, Inc. Class A – HAM:I76 - TradingView
Ironwood Pharmaceuticals Inc (IRWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Ironwood Pharmaceuticals, Inc. Class A Revenue Breakdown – BX:I76 - TradingView
Ironwood Pharmaceuticals, Inc. Class A Revenue Breakdown – SWB:I76 - TradingView
Ironwood Pharmaceuticals Inc (IRWD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IRWD|Ironwood Pharmaceuticals Inc|Price:3.910|Chg%:+0.200 - TradingKey
Ironwood Pharmaceuticals Inc (IRWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IRWD|Ironwood Pharmaceuticals Inc|Price:3.710|Chg%:-0.080 - TradingKey
Ironwood Pharmaceuticals Inc (I76.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
IRWD: Ironwood Pharmaceuticals IncOrdinary SharesClass A Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Ironwood Pharmaceuticals (IRWD) grants 137,036-share RSU new-hire award to CMO - Stock Titan
Ironwood Pharmaceuticals (IRWD) Jefferies 2024 Global Healthcare Conference Summary - Quartr
Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating - Moomoo
Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development, STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients - marketscreener.com
Here's why Ironwood Pharmaceuticals (IRWD) is a strong momentum stock - MSN
Ironwood’s 30-year medical chief retires as Phase 3 trial recruits - Stock Titan
Ironwood: Linzess Buys Time, But Apraglutide's rNPV Doesn't Close The Gap (NASDAQ:IRWD) - Seeking Alpha
Insider Sell Alert: Ronald Silver Sells Shares of Ironwood Pharm - GuruFocus
Form 4 Ironwood Pharmaceuticals Inc For: 9 July - Investing.com India
Form 4 Ironwood Pharmaceuticals Inc For: 9 July By Investing.com - Investing.com Nigeria
Ironwood Pharmaceuticals (IRWD) Declines 2.1% as Stock Approaches Key Support LevelNHNL Ratio - dars.gov.et
Ronald Silver, PFO, sells $578k in Ironwood Pharma stock By Investing.com - Investing.com Nigeria
Ronald Silver, PFO, sells $578k in Ironwood Pharma stock - Investing.com
Ironwood (IRWD) finance chief sells 127,890 shares in 10b5-1 stock plan - Stock Titan
Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (NASDAQ:IRWD) - TradingView
Form 144 IRONWOOD PHARMACEUTICALS For: 7 July By Investing.com - Investing.com Nigeria
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Proposed Common stock sale for IRWD (NASDAQ: IRWD) via Morgan Stanley Smith Barney - Stock Titan
Enterprise value to EBIT forward of Ironwood Pharmaceuticals, Inc. – NASDAQ:IRWD - TradingView
Price to earnings forward of Ironwood Pharmaceuticals, Inc. – NASDAQ:IRWD - TradingView
Price to sales forward of Ironwood Pharmaceuticals, Inc. – NASDAQ:IRWD - TradingView
Ironwood Pharmaceuticals stock follows its own business case. IRWD trades on Nasdaq. - Ad Hoc News
Ironwood Pharmaceuticals (IRWD) Gains From Strong Fiscal Q1 2026 Earnings Momentum - Yahoo Finance
Price to book forward of Ironwood Pharmaceuticals, Inc. – NASDAQ:IRWD - TradingView
IRWD Forecast — Price Target — Prediction for 2027 - TradingView
Gastroparesis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharma, Ironwood Pharma, Takeda - Barchart.com
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker - The Globe and Mail
Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (BX:I76) - TradingView
Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (SWB:I76) - TradingView
Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (MUN:I76) - TradingView
I76 Forecast — Price Target — Prediction for 2027 - TradingView
5 Small Drug Stocks to Invest in Amid a Biotech Comeback - Yahoo Finance
Ironwood Pharmaceuticals (IRWD) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Ironwood Pharmaceuticals Inc (IRWD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Ironwood Pharmaceuticals StockAnalyst snapshot and sector review at week’s end - AD HOC NEWS
IRWD News | IRONWOOD PHARMACEUTICALS INC (NASDAQ:IRWD) - ChartMill
Ironwood Pharmaceuticals (IRWD) adds 10M shares to 2019 equity incentive plan - Stock Titan
Ironwood Pharmaceuticals Inc - TradingKey
Ironwood Pharmaceuticals Inc (IRWD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
0.30%
2.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):